Bacterial Translocation Up-regulates GTP-Cyclohydrolase I in Mesenteric Vasculature of Cirrhotic Rats

Hepatology

Volumn 38, Issue 6, 2003, Pages 1508-1515

  Wiest, Reiner ^a   Cadelina, Gregory ^a   Milstien, Sheldon ^c   McCuskey, Robert S ^d   Garcia Tsao, Guadalupe ^a,b   Groszmann, Roberto J ^a,b  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^d UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; NITRIC OXIDE; TETRAHYDROBIOPTERIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCITES; BACTERIAL TRANSLOCATION; BACTERIUM CULTURE; BIOASSAY; BIOSYNTHESIS; BLOOD LEVEL; CELL LYSATE; CHEMOLUMINESCENCE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTOXEMIA; ENZYME ACTIVITY; ENZYME ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KINETICS; LIMULUS; LIVER CIRRHOSIS; MEAN ARTERIAL PRESSURE; MEASUREMENT; MESENTERY BLOOD FLOW; MESENTERY LYMPH NODE; METABOLITE; NONHUMAN; PRIORITY JOURNAL; RAT; STANDARD; TURBIDIMETRY; UPREGULATION; VASODILATATION;

EID: 0345448869     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hep.2003.09.039     Document Type: Article

References (50)

1. Deitch EA. Bacterial translocation of the gut flora. J Trauma 1990;30:S184-189.
2. Garcia-Tsao G, Lee FY, Barden GE, Cartun R, West AB. Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites. Gastroenterology 1995;108:1835-1841.
3. Llovet JM, Bartoli R, March F, Planas R, Vinado B, Cabre E, Arnal J, et al. Translocated intestinal bacteria cause spontaneous bacterial peritonitis in cirrhotic rats: molecular epidemiologic evidence. J Hepatol 1998;28:307-313.
4. Runyon BA, Squier S, Borzio M. Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis. J Hepatol 1994;21:792-796.
5. Cirera I, Bauer TM, Navasa M, Vila J, Grande L, Taura P, Fuster J, et al. Bacterial translocation of enteric organisms in patients with cirrhosis. J Hepatol 2001;34:32-37.
6. Lin RS, Lee FY, Lee SD, Tsai YT, Lin HC, Lu RH, Hsu WC, et al. Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation. J Hepatol 1995;22:165-172.
7. Lumsden AB, Henderson JM, Kutner MH. Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis. HEPATOLOGY 1988;8:232-236.
8. Wiest R, Garcia-Tsao G, Cadelina G, Das S, Shah V, Groszmann RJ. Bacterial translocation to mesenteric lymph nodes enhances eNOS-derived NO overproduction in mesenteric vasculature of cirrhotic rats: role for impairment in vascular contractility. J Clin Invest 1999;104:1223-1233.
9. Battista S, Bar F, Mengozzo G, Zanon E, Grosso M, Molino G. Hyperdynamic circulation in patients with cirrhosis: direct measurement of nitric oxide levels in hepatic and portal veins. J Hepatology 1997;26:75-80.
10. Wiest R, Groszmann RJ. The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough. HEPATOLOGY 2001;35:478-491.
11. Sessa WC. The nitric oxide synthase family of proteins. J Vasc Res 1994;31:131-143.
12. Martin PY, Xu DL, Niederberger M, Weigert A, Tsai P, St John J, Gines P, et al. Upregulation of endothelial constitutive NOS: a major role in the increased NO production in cirrhotic rats. Am J Physiol 1996;270:F494-499.
13. Morales-Ruiz M, Jimenez W, Perez-Sala D, Ros J, Leivas A, Lamas S, Rivera F, et al. Increased nitric oxide synthase expression in arterial vessels of cirrhotic rats with ascites. HEPATOLOGY 1996;24:1481-1486.
14. Heller J, Sogni P, Tazi KA, C̀hagneau C, Poirel O, Moreau R, Lebrec D, et al. Abnormal regulation of aortic NOS2 and NOS3 activity and expression from portal vein-stenosed rats after lipopolysaccharide administration. HEPATOLOGY 1999;30:698-704.
15. Guarner C, Soriano G, Tomas A, Bulbena O, Novella MT, Balanzo J, Vilardell F, et al. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. HEPATOLOGY 1993;18:1139-1143.
16. Chu CJ, Lee FY, Wang SS, Lu RH, Tsai YT, Lin HC, Hou MC, et al. Hyperdynamic circulation of cirrhotic rats with ascites: role of endotoxin, tumour necrosis factor and nitric oxide. Clin Sci 1997;93:219-225.
17. Werner ER, Werner-Felmayer G, Wachter H, Mayer B. Biosynthesis of nitric oxide: dependence on pteridine metabolism. Rev Physiol Biochem Pharmacol 1996;127:97-135.
18. Stroess E, Kastelein J, Cosentino F, Erkelens W, Wever R, Koomans H, Luscher T, et al. Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. J Clin Invest 1997;99:41-46.
19. Wever RMF, Van Dam T, Van Rijn HJM, DeGroot F, Rabelink TJ. Tetrahydrobiopterin regulates superoxide and nitric oxide generation by recombinant endothelial nitric oxide synthase. Biochem Biophys Res Commun 1997;237:340-344.
20. Van Amsterdam JG, Werner J. Tetrahydrobiopterin induces vasodilation via enhancement of cGMP level. Eur J Pharmacol 1992;215:349-350.
21. Rosenkranz-Weiss P, Sessa WC, Milstien S, Kaufman S, Watson CA, Pober JS. Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells. Elevations in tetrahydrobiopterin levels enhance endothelial nitric oxide synthase specific activity [see comments]. J Clin Invest 1994;93:2236-2243.
22. Schaffner A, Blau N, Scheemann M, Steurer J, Edgell CS, Schoedon G. Tetrahydrobiopterin as another EDRF in man. Biochem Biophys Res Commun 1994;205:516-523.
23. Rosenblum WI. Tetrahydrobiopterin, a cofactor for nitric oxide synthase, produces endothelium-dependent dilation of mouse pial arterioles. Stroke 1997;28:186-189.
24. Schoedon G, Blau N, Schneemann M, Flury G, Schaffner A. Nitric oxide production depends on preceding tetrahydrobiopterin synthesis by endothelial cells: selective suppression of induced nitric oxide production by sepiapterin reductase inhibitors. Biochem Biophys Res Commun 1994;199:504-510.
25. Auerbach G, Nar H. The pathway from GTP to tetrahydrobiopterin: three-dimensional structures of GTP cyclohydrolase I and 6-pyruvoyl tetrahydropterin synthase. Biol Chem 1997;378:185-192.
26. Katusic ZS, Stelter A, Milstien S. Cytokines stimulate GTP cyclohydrolase I gene expression in cultured human umbilical vein endothelial cells. Arterioscler Thromb Vasc Biol 1998;18:27-32.
27. Hattori Y, Oka M, Kasai K, Nakanishi N, Shimoda S. Lipopolysaccharide treatment in vivo induces tissue expression of GTP cyclohydrolase I mRNA. FEBS Lett 1995;368:336-338.
28. Werner-Felmayer G, Prast H, Werner ER, Philippu A, Wachter H. Induction of GTP cyclohydrolase I by bacterial lipopolysaccharide in the rat. FEBS Lett 1993;322:223-226.
29. Sieber CC, Lopez-Talavera JC, Groszmann RJ. Role of nitric oxide in the in vitro splanchnic vascular hyporeactivity in ascitic cirrhotic rats. Gastroenterology 1993;104:1750-1754.
30. Tsutsui M, Milsrien S, Katusic ZS. Effect of tetrahydrobiopterin on endothelial function in canine middle cerebral arteries. Circ Res 1996;79:336-342.
31. McGregor DD. The effect of sympathetic nerve stimulation on vasoconstrictor responses in perfused mesenteric vessels of the rat. J Physiol (Lond) 1965;177:21-30.
32. Atucha NM, Shah V, Garcia-Cardena G, Sessa WE, Groszmann RJ. Role of endothelium in the abnormal response of mesenteric vessels in rats with portal hypertension and liver cirrhosis. Gastroenterology 1996;111:1627-1632.
33. Bigatello LM, Broitman SA, Fattori L, DiPaoli M, Pontello M, Bevilacqua G, Nespoli A. Endotoxemia, encephalopathy, and mortality in cirrhotic patients. Am J Gastroenterol 1987;82:11-15.
34. Mainous MR, Ertel W, Chaudry IH, Deitch EA. The gut: a cytokine-generating organ in systemic inflammation? Shock 1995;4:193-199.
35. Deitch EA, Xu D, Franko L, Ayala A, Chaudry IH. Evidence favoring the role of the gut as a cytokine-generating organ in rats subjected to hemorrhagic shock. Shock 1994;1:141-145.
36. Mainous MR, Tso P, Berg RD, Deitch EA. Studies of the route, magnitude, and time course of bacterial translocation in a model of systemic inflammation. Arch Surg 1991;126:33-37.
37. Thöny B, Auerbach G, Blau N. Tetrahydrobiopterin biosynthesis, regeneration and functions. Biochem J 2000;347:1-16.
38. Werner-Felmayer G, Werner ER, Fuchs D, Hausen A, Reibnegget G, Schmidt K, Weiss G, et al. Pteridine biosynthesis in human endothelial cells. Impact on nitric oxide-mediated formation of cyclic GMP. J Biol Chem 1993;268:1842-1846.
39. Hattori Y, Gross SS. GTP cyclolaydrolase I mRNA is induced by LPS in vascular smooth muscle: characterization, sequence and relationship to nitric oxide synthase. Biochern Biophys Res Commun 1993;195:435-441.
40. Hattori Y, Nakanishi N, Kasai K, Shimoda S. GTP cyclohydrolase I mRNA induction and tetrahydrobiopterin synthesis in human endothelial cells. Biochim Biophys Acta 1997;1358:61-66.
41. Old LJ. Tumor necrosis factor (TNF). Science 1985;230:630-632.
42. Schmidt K, Werner ER, Mayer B, Wachter H, Kukovetz WR. Tetrahydrobiopterin-dependent formation of endothelium-derived relaxing factor (nitric oxide) in aortic endothelial cells. Biochem J 1992;281:297-300.
43. Bune AJ, Brand MP, Heales SJ, Shergill JK, Cammack R, Cook HT. Inhibition of tetrahydrobiopterin synthesis reduces in vivo nitric oxide production in experimental endotoxic shock. Biochem Biophys Res Commun 1996;220:13-19.
44. Wiest R, Groszmann RJ. Nitric oxide and portal hypertension: its role in the regulation of intrahepatic and splanchnic vascular resistance. Semin Liver Dis 1999;19:411-426.
45. Fernandez M, Garcia-Pagan JC, Casadevall M, Bernadich C, Piera C, Whittle BJ, Pique JM, et al. Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal-hypertensive rats. Gastroenterology 1995;108:1487-1495.
46. Salvemini D, Korbut R, Anggard E, Vane JR. Immediate release of a nitric oxide-like factor from bovine aortic endothelial cells by Escherichia coli lipopolysaccharide. Proc Natl Acad Sci U S A 1990;87:2593-2597.
47. Szabo C, Mitchell JA, Thiemermann C, Vane JR. Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock. Br J Pharmacol 1993;108:786-792.
48. Gross SS, Jones CL, Hattori Y, Raman CS. Tetrahydrobiopterin: an essential cofactor of nitric oxide synthase with an elusive role. Nitric Oxide Biology and Pathobiology. San Diego: Academic; 2000:167-187.
49. Raman CS, Li H, Martasek P, Kral V, Masters BS, Poulos TL. Crystal structure of constitutive endothelial nitric oxide synthase: a paradigm for pterin function involving a novel metal center. Cell 1998;95:939-950.
50. Wei C, Wang Z, Meade A, McDonald J, Stuehr D. Why do nitric oxide synthases use tetrahydrobiopterin? J Inorg Biochem 2002;91:618.